<div>
  <ul>
    <li>
      <p>
        Clinical trial management system company uMotif announced a partnership with ActiGraph, specifically to incorporate the use of ActiGraph&rsquo;s wearables into clinical trials and provide a combined solution to researchers and drug development customers.
      </p>
    </li>
    <li>
      <p>
        Specifically, the partnership seeks to combine electronic patient-reported outcomes from uMotif&rsquo;s platform with objective data collected from ActiGraph&rsquo;s wearable devices into &ldquo;a single experience.&rdquo;&nbsp;
      </p>
    </li>
    <li>
      <p>
        uMotif is a UK-based clinical trial management platform that was designed to simplify the clinical trial process for patients and can be used across multiple phases
      </p>
    </li>
    <li>
      <p>
        ActiGraph is a manufacturer focusing on medical- grade wearable devices, with over 20 years of experience. The company has supported over 200 clinical trials as of February 2023 and supported over 20,000 scientific publications. The company&rsquo;s flagship devices are worn on the wrist and can be connected to the company&rsquo;s CentrePoint platform for data collection and management.
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://www.outsourcing-pharma.com/Article/2023/02/13/umotif-and-actigraph-announce-partnership-during-scope-2023">
      Outsourcing Pharma
    </a>
  </p>
</div>


All Updates

uMotif and ActiGraph partner for use of wearables in clinical trials

uMotif raises USD 25.5 million from Athyrium Capital